Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Three ablation strategies using very high-power short-duration catheter in paroxysmal atrial fibrillation: The Q-INDEX randomized trial.

Created on 23 Oct 2026

Authors

So-Ryoung Lee, Youngjin Cho, Seokmoon Han, Kyung-Yeon Lee, Hyo-Jeong Ahn, Soonil Kwon, Koung Mi Kang, Sang Weon Park, Seil Oh, Hyoung-Seob Park, Eue-Keun Choi

Published in

Heart rhythm. Oct 23, 2026. Epub Oct 23, 2026.

Abstract

Very high-power short-duration (vHPSD; 90 W/4 sec) ablation shortens pulmonary vein isolation (PVI) but produces shallower lesions that may be inadequate in the thick anterior left atrium.
To compare vHPSD, ablation index (AI)-guided, and hybrid strategies for PVI in paroxysmal atrial fibrillation.
In this multicenter, randomized, open-label trial, 150 patients with paroxysmal atrial fibrillation were assigned 1:1:1 with the QDOT MICRO catheter to (1) AI-guided (AI 500 anterior, 400 elsewhere), (2) hybrid (AI-guided anterior [AI 500], vHPSD elsewhere), or (3) vHPSD (90 W/4 sec, all segments). The primary endpoint was total ablation time; secondary endpoints included acute PV reconnection, safety, and 1-year freedom from atrial arrhythmia.
Acute PVI was achieved in all patients. Total ablation time was longest with AI-guided and shortest with vHPSD ablation (median 2220 vs 1450 vs 794 sec; P < .001). Acute reconnection across the 14 PV segments was lowest with AI-guided and highest with vHPSD (7.7% vs 9.4% vs 10.6%; P = .40). One-year freedom from atrial arrhythmia was 92.0%, 85.4%, and 77.6%, respectively (log-rank P = .13; for AI-guided vs vHPSD; P = .049). No tamponade occurred; steam pops occurred only in the 90 W groups. Two minor periprocedural strokes occurred (both vHPSD; full recovery), and silent cerebral lesions on magnetic resonance imaging did not differ among the groups (5%, 10%, 0%; P = .35).
Uniform vHPSD more than halved PVI ablation time but was associated with the lowest 1-year efficacy, whereas the hybrid strategy preserved efficiency without significant loss of durability. These exploratory findings-from a trial powered for ablation time-support region-tailored lesion depth in point-by-point ablation and warrant confirmation.

PMID:
42909425
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 23
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement